Therapy Resistance in Neoadjuvantly Treated Gastric Cancer and Cancer of the Gastroesophageal Junction is Associated with an Increased Expression of Immune Checkpoint Inhibitors—Comparison Against a Therapy Naïve Cohort

With recent studies uncovering the complex landscape of immune checkpoint regulators in gastric cancer (GC), we aimed to characterize the expression of the checkpoint proteins V-domain Ig suppressor of T-cell activation (VISTA), programmed cell death 1 ligand 1 (PD-L1), and programmed cell death pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoop, Hauke, Bregenzer, Anna, Halske, Christine, Behrens, Hans-Michael, Krüger, Sandra, Egberts, Jan-Hendrik, Röcken, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931207/
https://www.ncbi.nlm.nih.gov/pubmed/31865179
http://dx.doi.org/10.1016/j.tranon.2019.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931207/
https://www.ncbi.nlm.nih.gov/pubmed/31865179
http://dx.doi.org/10.1016/j.tranon.2019.11.004

Ejemplares similares